Biotage AB (ST:BIOT) — Stock Price

Skr143.20 SEK
▲ 0.00% today

Biotage AB (ST:BIOT) is currently trading at Skr143.20 SEK, up 0.00% today. Over the past 52 weeks, shares have ranged between Skr143.20 and Skr143.20. This page tracks Biotage AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BIOT market cap.

Biotage AB (BIOT) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Biotage AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Daily price history is not currently available for Biotage AB.

Biotage AB Income Statement — Revenue, Profit & Earnings by Year

Biotage AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Skr2.06 Billion Skr1.86 Billion Skr1.57 Billion Skr1.23 Billion Skr1.09 Billion
Cost of Revenue Skr767.00 Million Skr849.00 Million Skr618.00 Million Skr477.00 Million Skr425.55 Million
Gross Profit Skr1.29 Billion Skr1.01 Billion Skr948.00 Million Skr755.00 Million Skr666.73 Million
Research & Development Skr180.00 Million Skr95.00 Million Skr109.00 Million Skr91.00 Million Skr72.12 Million
SG&A Skr235.00 Million Skr212.00 Million Skr150.00 Million Skr117.00 Million Skr75.64 Million
Total Operating Expenses Skr906.00 Million Skr637.00 Million Skr656.00 Million Skr499.00 Million Skr479.89 Million
Operating Income Skr383.00 Million Skr376.00 Million Skr327.00 Million Skr271.00 Million Skr206.19 Million
EBITDA Skr530.00 Million Skr432.00 Million Skr431.00 Million Skr323.00 Million Skr278.10 Million
EBIT Skr345.00 Million Skr338.00 Million Skr353.00 Million Skr272.00 Million Skr226.07 Million
Interest Expense Skr43.00 Million Skr11.00 Million Skr5.00 Million Skr3.00 Million Skr3.34 Million
Income Before Tax Skr328.00 Million Skr303.00 Million Skr348.00 Million Skr269.00 Million Skr222.73 Million
Income Tax Expense Skr44.00 Million Skr57.00 Million Skr80.00 Million Skr64.00 Million Skr47.40 Million
Net Income Skr284.00 Million Skr246.00 Million Skr268.00 Million Skr205.00 Million Skr175.00 Million

Biotage AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Biotage AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Skr5.10 Billion Skr4.93 Billion Skr2.34 Billion Skr1.99 Billion Skr1.43 Billion
Total Current Assets Skr1.36 Billion Skr1.45 Billion Skr1.03 Billion Skr774.00 Million Skr751.62 Million
Cash & Equivalents Skr434.00 Million Skr594.00 Million Skr441.00 Million Skr311.00 Million Skr371.32 Million
Short-term Investments — Skr-4.00 Million — Skr-4.00 Million Skr-1.84 Million
Net Receivables Skr382.00 Million Skr321.00 Million Skr265.00 Million Skr207.00 Million Skr207.45 Million
Inventory Skr458.00 Million Skr437.00 Million Skr305.00 Million Skr237.00 Million Skr159.82 Million
Property, Plant & Equipment Skr330.00 Million Skr284.00 Million Skr162.00 Million Skr128.00 Million Skr104.00 Million
Goodwill Skr2.56 Billion Skr2.39 Billion Skr794.00 Million Skr741.00 Million Skr290.21 Million
Total Liabilities Skr991.00 Million Skr1.27 Billion Skr702.00 Million Skr620.00 Million Skr444.40 Million
Total Current Liabilities Skr582.00 Million Skr705.00 Million Skr417.00 Million Skr313.00 Million Skr217.36 Million
Long-term Debt Skr150.00 Million Skr150.00 Million Skr150.00 Million Skr150.00 Million Skr110.00 Million
Net Debt Skr-184.00 Million Skr-335.00 Million Skr-224.00 Million Skr-108.00 Million Skr-158.63 Million
Total Stockholder Equity Skr4.11 Billion Skr3.66 Billion Skr1.64 Billion Skr1.37 Billion Skr990.04 Million
Retained Earnings Skr1.54 Billion Skr1.38 Billion Skr1.23 Billion Skr1.06 Billion Skr956.11 Million

Biotage AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Biotage AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Skr413.00 Million Skr284.00 Million Skr341.00 Million Skr353.00 Million Skr279.05 Million
Capital Expenditures Skr169.00 Million Skr26.00 Million Skr70.00 Million Skr56.00 Million Skr60.94 Million
Free Cash Flow Skr244.00 Million Skr258.00 Million Skr271.00 Million Skr297.00 Million Skr218.11 Million
Investing Cash Flow Skr-456.00 Million Skr35.00 Million Skr-84.00 Million Skr-341.00 Million Skr-61.32 Million
Financing Cash Flow Skr-156.00 Million Skr-142.00 Million Skr-133.00 Million Skr-82.00 Million Skr-22.72 Million
Dividends Paid Skr128.00 Million Skr106.00 Million Skr102.00 Million Skr98.00 Million Skr98.00 Million
Stock-Based Compensation Skr1.00 Million Skr3.00 Million Skr15.00 Million Skr7.00 Million —
Depreciation Skr185.00 Million Skr122.00 Million Skr102.00 Million Skr75.00 Million Skr73.90 Million
Change in Cash Skr-160.00 Million Skr153.00 Million Skr130.00 Million Skr-60.00 Million Skr185.46 Million

Biotage AB Earnings History — EPS Actual vs. Analyst Estimates

Track Biotage AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 21, 2026 — — —
Oct 23, 2025 — — —
Aug 06, 2025 — 0.34 —
Apr 22, 2025 0.32 0.40 -20.00%
Feb 19, 2025 1.42 1.38 +2.62%
Oct 23, 2024 0.68 0.83 -18.07%
Jul 16, 2024 0.67 0.84 -20.24%
Apr 25, 2024 0.55 0.58 -5.17%